Featured Research

from universities, journals, and other organizations

Inexpensive rinsing effective at reducing post-op infection following joint replacement surgery

Date:
February 21, 2011
Source:
Rush University Medical Center
Summary:
A rinsing technique with betadine that costs just a little over one dollar per patient may significantly reduce the infection rate following total knee and hip joint replacement surgery, according to a new study.

A rinsing technique with betadine that costs just a little over one dollar per patient may significantly reduce the infection rate following total knee and hip joint replacement surgery according to a study by researchers at Rush University Medical Center.

The study, presented at the American Association of Orthopedic Surgeons 2011 Annual Meeting, found that a three minute diluted betadine lavage combined with painting of the skin with a 10% betadine solution prior to surgical closure nearly eliminated early deep post-operative infection.

Deep periprosthetic joint infection is a rare but devastating complication associated with total joint replacement. Despite aseptic techniques, careful skin preparation and prophylactic antibiotics, deep infections still occur with a prevalence ranging from 0.3% to 1.9%.

Previous research has shown that a diluted betadine lavage of the surgical wound prior to closure reduces the rate of post-operative infection in orthopedic, urologic, cardiovascular and general surgery but it has not been previously studied in total joint arthroplasty.

"Betadine is safe, inexpensive, simple to use, and readily available within most operating rooms," said study author Dr. Craig Della Valle, associate professor of orthopedic surgery at Rush. "In addition, betadine is effective on many types of bacteria including methicillin-resistant Staphylococcus Aureus (MRSA).

Researchers implemented a protocol for primary total knee and total hip arthroplasty in which the wound is soaked with the diluted betadine solution for three minutes following implantation of the prosthetic components. This is followed by a pulsating lavage of normal saline without antibiotics. Prior to final closure, betadine is applied to the skin surrounding the incision. Prior to this protocol, wounds were lavaged with normal saline only.

Acute post-operative deep infection was diagnosed in 18 out of the 1862 cases performed prior to the initiation of the betadine lavage protocol and in only one of the 688 total joint arthroplasties following initiation of this protocol; a reduction of the infection rate from 0.97% to 0.15%. There were no side complications associated with the treatment.

The study authors caution there are some limitations to the study. Changes in the surgeon's technique occurred over the time of the study, and it was not feasible to determine the impact of these changes on the rate of infection. These included variations in the incision size, suture material, and type of skin sealant.


Story Source:

The above story is based on materials provided by Rush University Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

Rush University Medical Center. "Inexpensive rinsing effective at reducing post-op infection following joint replacement surgery." ScienceDaily. ScienceDaily, 21 February 2011. <www.sciencedaily.com/releases/2011/02/110217161119.htm>.
Rush University Medical Center. (2011, February 21). Inexpensive rinsing effective at reducing post-op infection following joint replacement surgery. ScienceDaily. Retrieved July 24, 2014 from www.sciencedaily.com/releases/2011/02/110217161119.htm
Rush University Medical Center. "Inexpensive rinsing effective at reducing post-op infection following joint replacement surgery." ScienceDaily. www.sciencedaily.com/releases/2011/02/110217161119.htm (accessed July 24, 2014).

Share This




More Health & Medicine News

Thursday, July 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com
Condemned Man's US Execution Takes Nearly Two Hours

Condemned Man's US Execution Takes Nearly Two Hours

AFP (July 24, 2014) America's death penalty debate raged Thursday after it took nearly two hours for Arizona to execute a prisoner who lost a Supreme Court battle challenging the experimental lethal drug cocktail. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com
China's Ageing Millions Look Forward to Bleak Future

China's Ageing Millions Look Forward to Bleak Future

AFP (July 24, 2014) China's elderly population is expanding so quickly that children struggle to look after them, pushing them to do something unexpected in Chinese society- move their parents into a nursing home. Duration: 02:07 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins